What is VKTX's dilution risk score?

VKTX has a latest available DilutionScore record of 35/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for VKTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for VKTX?

DilutionWatch tracks 25 SEC filing types for VKTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect VKTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For VKTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for VKTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for VKTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

VKTX Dilution Risk Score: 35/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

20

💰 Cash Runway

65

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

💰 Capital Raise model 15%

• Under 12 months cash (8mo)

🔔 Track VKTX — Get forecast alerts →

Market Data

Market Cap$3.80B

Shares Outstanding116.65M

Float113.28M

Cash$125.75M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	35/100	DilutionWatch score record
Shares Outstanding	116.65M	Verified float table or market cache
Public Float	113.28M	Verified float table or market cache
Market Cap	$3.80B	Market data cache
Cash Runway	7.7 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	None in current score inputs	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 17.2% shares (2026Q1 vs prior)

418 institutional holders · 99.64M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 10.03M shares

#2 MORGAN STANLEY 9.82M shares

#3 BlackRock, Inc. 6.88M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest22.19M

Days to Cover12.4

% of Float19.6%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2017-03-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual VKTX Dilution Snapshot

Viking Therapeutics, Inc. (VKTX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: September 12, 2026.

Recent SEC activity tracked for VKTX: xbrl on 2017-03-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.